![Amanda Redfern](https://profiles-cardiff.imgix.net/attachments/2593?w=200&h=200&auto=format&crop=faces&fit=crop&q=90")
Dr Amanda Redfern
Facility Lead (Microarray and NGS), Central Biotechnology Services
- RedfernAJ1@caerdydd.ac.uk
- +44 29208 79115
- Adeilad Henry Wellcome ar gyfer Ymchwil Biofeddygol, Ystafell GF21, Ysbyty Athrofaol Cymru, Parc y Mynydd Bychan, Caerdydd, CF14 4XN
Cyhoeddiad
2018
- Carboni, L. et al. 2018. Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression. Neuropsychopharmacology 43, pp. 2134-2145. (10.1038/s41386-018-0117-6)
2012
- Mattis, V. B. et al. 2012. Induced pluripotent stem cells from patients with Huntington's Disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11(2), pp. 264-278. (10.1016/j.stem.2012.04.027)
- Feyeux, M. et al. 2012. Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Human Molecular Genetics 21(17), pp. 3883-3895. (10.1093/hmg/dds216)
2005
- Morton, A. J., Hunt, M. J., Hodges, A. K., Lewis, P. D., Redfern, A. J., Dunnett, S. B. and Jones, L. 2005. A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. European Journal of Neuroscience 21(4), pp. 855-870. (10.1111/j.1460-9568.2005.03895.x)
Articles
- Carboni, L. et al. 2018. Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression. Neuropsychopharmacology 43, pp. 2134-2145. (10.1038/s41386-018-0117-6)
- Mattis, V. B. et al. 2012. Induced pluripotent stem cells from patients with Huntington's Disease show CAG-repeat-expansion-associated phenotypes. Cell Stem Cell 11(2), pp. 264-278. (10.1016/j.stem.2012.04.027)
- Feyeux, M. et al. 2012. Early transcriptional changes linked to naturally occurring Huntington's disease mutations in neural derivatives of human embryonic stem cells. Human Molecular Genetics 21(17), pp. 3883-3895. (10.1093/hmg/dds216)
- Morton, A. J., Hunt, M. J., Hodges, A. K., Lewis, P. D., Redfern, A. J., Dunnett, S. B. and Jones, L. 2005. A combination drug therapy improves cognition and reverses gene expression changes in a mouse model of Huntington's disease. European Journal of Neuroscience 21(4), pp. 855-870. (10.1111/j.1460-9568.2005.03895.x)